Advantice Connects On Second Swing To Support Nail Fungus Claims Challenged By Arcadia
Without study it conducted after first review, Advantice wouldn’t have changed NAD’s conclusion on firm’s claim its product “starts improving nail appearance in just 2 days.” Without Arcadia’s premature publication of recommendation following NAD’s first review, Advantice wouldn’t have second chance.
You may also be interested in...
Arcadia prohibited from arguing against Advantice’s appeal of National Advertising Division decision that Kerasal Fungal Nail Renewal ad claims weren’t supported. Arcadia violated confidentiality rule by publicizing NAD decision before the review was officially closed.
Kramer Laboratories' claims for Fungi-Nail athlete's foot product referred to FDA and FTC after it refuses to comply with NAD's recommendation to modify the name. The firm, which agreed to modify packaging and commercial claims, was warned by FDA about the brand in 2005.
Nasadol CBD Nasal Sprays not only are violative for claims unallowed for CBD, but for containing CBD. FDA also warns online pharmacy about fraudulent OTC COVID-19 cure kit.